AuraGenix NV  

(Public, ETR:AUI)   Watch this stock  
0.110
Delayed:   10:13AM GMT+2
ETR data delayed by 15 mins - Disclaimer
Currency in EUR
Range     -
52 week 11.00 - 50.00
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares     -
Beta     -
Inst. own     -

Address

Keizersgracht 62-64
AMSTERDAM, 1015 CS
Netherlands
+31-20-5206831 (Phone)
+31-20-5207510 (Fax)

Website links

Description

AuraGenix NV is a company based in the Netherlands that is engaged in the provision of pharmaceutical products and medical devices. The Company focuses its activities on the medical aesthetic and therapeutic device markets. AuraGenix NV offers, under the brand Revanesse, a range of dermal fillers that are based on hyaluronic acid gel. Revanesse product line consists of Revanesse Ultra, which is a filler used for smoothing out deeper wrinkles and folds, such as glabellar folds, peri-oral wrinkles, nasolabial folds, marionette lines and oral commissure; ReDexis, a dermal filler that regenerates the skin and is designed to treat deeper lines, wrinkles, folds and lip augmentation; ReDexis Ultra, a product used for shaping and facial contouring by injection into the subcutaneous restoring lost volume with results expected to last up to 24 months, and Revanesse Pure that is applied for the purpose of rejuvenating and revitalizing the skin.